MAGE-A3 112-120 (HLA-A*02:01)

MAGE-A3 112-120 (HLA-A*02:01)
€50.00 *

Prices plus VAT plus shipping costs

Delivery time 3 weeks
sterile and endotoxin free Delivery Format:
The product is supplied freeze dried as trifluoracetate salt

Amount in mg:

make your choice

  • EP11347_1
KVAELVHFL is a linear peptidic epitope (epitope ID33943) studied as part of Melanoma-associated... more
Product information "MAGE-A3 112-120 (HLA-A*02:01)"
KVAELVHFL is a linear peptidic epitope (epitope ID33943) studied as part of Melanoma-associated antigen 9 from Homo sapiens (human) and Melanoma-associated antigen 3 from Homo sapiens (human). This epitope has been studied for immune reactivity in, tested in T cell assays and MHC ligand assays Antigen Peptide MAGE-A3 112-120 (HLA-A*02:01) KVAELVHFL for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.KVAELVHFL is a linear peptidic epitope (epitope ID33943) studied as part of Melanoma-associated antigen 9 from Homo sapiens (human) and Melanoma-associated antigen 3 from Homo sapiens (human). This epitope has been studied for immune reactivity in, tested in T cell assays and MHC ligand assays Antigen Peptide MAGE-A3 112-120 (HLA-A*02:01) KVAELVHFL for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

 
Sequence:KVAELVHFL
Gene:MAGE A3
Delivery: 3 weeks
C-Terminus:OH
N-Terminus:H
Purity:95%
Amount:1 mg
Counter Ion:TFA
Protein:Melanoma-associated antigen
Species:Human
Allele:HLA-A*02:01
Application :Flow Cytometry
Indication :Cancer;Melanoma
Dokumente - Protokolle - Downloads more
Viewed